Pigment epithelium-derived factor expression prolongs survival and enhances the cytotoxicity of low-dose chemotherapy in castration-refractory prostate cancer

There is currently no cure for advanced castration-refractory prostate cancer (CRPC) despite the recent approval of several new therapeutic agents. We report here the anti-tumor effect of the angio-inhibitory pigment epithelium-derived factor (PEDF) in the metastatic LNCaP-derivative CRPC CL1 model...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelius, T, Martinez-Marin, D, Hirsch, J, Miller, B, Rinard, K, Lopez, J, de Riese, W, Filleur, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047872/
https://www.ncbi.nlm.nih.gov/pubmed/24810046
http://dx.doi.org/10.1038/cddis.2014.180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4047872/
https://www.ncbi.nlm.nih.gov/pubmed/24810046
http://dx.doi.org/10.1038/cddis.2014.180

Ejemplares similares